ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
Holding IPA?
Track your performance easily

ImmunoPrecise Antibodies (IPA) Ownership - Who Owns ImmunoPrecise Antibodies?

143 Followers

ImmunoPrecise Antibodies (IPA) Ownership Overview

1.21%0.06%0.10%98.63%
0.10% Other Institutional Investors
98.63% Public Companies and
Individual Investors
The ownership structure of ImmunoPrecise Antibodies (IPA) stock is a mix of institutional, retail, and individual investors. , 1.21% is owned by Insiders, and 98.63% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 03, 2024
Jennifer Lynne Bath
President & Chief Executive Officer
xxxxxxxxxxxxx
$10008
Aug 03, 2024
Barry Alan Springer
Non Executive,director
xxxxxxxxxxxxx
$4350
Aug 02, 2024
Kristin Taylor
Chief Financial Officer
xxxxxxxxxxxxx
$8200
Aug 02, 2024
Mitch Levine
Chairman,director
xxxxxxxxxxxxx
$8156

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
260,818Insider0.93%114,760
30,000Insider0.11%13,200
20,000Insider0.07%8,800
17,484Institution0.06%7,693
15,000Insider0.05%6,600
9,542Insider0.03%4,198
1,950Insider<0.01%858

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
17,484Institution0.06%7,693

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns ImmunoPrecise Antibodies (IPA)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 1.21% is held by insiders, and 98.63% is held by retail investors.
    What percentage of ImmunoPrecise Antibodies (IPA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.10% of ImmunoPrecise Antibodies (IPA) stock is held by institutional investors.
      What percentage of ImmunoPrecise Antibodies (IPA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 98.63% of ImmunoPrecise Antibodies (IPA) stock is held by retail investors.
        Who owns the most shares of ImmunoPrecise Antibodies (IPA)?
        Jennifer Lynne Bath owns the most shares of ImmunoPrecise Antibodies (IPA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis